Review: Abnormal T cell signal transduction in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 46, Issue 5, 2002, Pages 1139-1154

  Kammer, Gary M ^a   Perl, Andras ^b   Richardson, Bruce C ^c   Tsokos, George C ^d,e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; T LYMPHOCYTE RECEPTOR;

ENZYME ACTIVITY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; IMMUNOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0036560022     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10192     Document Type: Review

References (123)

1. Systemic lupus erythematosus in the elderly
2. T lymphocyte immune dysfunctions in systemic lupus erythematosus
3. T lymphocytes, natural killer cells, cytokines, and immune regulation
4. Overview of cellular immune function in systemic lupus erythematosus
5. Impaired recovery and cytolytic function of CD56+ T and non-T cells in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: Studies in unselected patients and monozygotic disease-discordant twins
6. The immunoregulatory effects of NK cells: The role of TGF-β and implications for autoimmunity
7. The T cell enigma in lupus
8. Immune cell signaling defects in lupus: Activation, anergy and death
9. Molecular aberrations in human systemic lupus erythematosus
10. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
11. From TcR engagement to T cell activation: A kinetic view of T cell behavior
12. The ITAMs associated with the B-cell and T-cell receptors are phosphorylated by protein tyrosine kinases of the Src family
13. Altered pattern of TcR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus: Deficient expression of the T cell receptor zeta chain
14. Diminished levels of T cell receptor ζ chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus
15. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor ζ chain messenger RNA
16. Polymorphisms/mutations of the TcRζ-chain promoter and 3′ untranslated region and selective expression of TcR-ζ-chain with an alternatively spliced 3′ untranslated region in patients with systemic lupus erythematosus
17. Generation and biochemical analysis of human effector CD4 T cells: Alterations in tyrosine phosphorylation and loss of CD3ζ expression
18. Fcε receptor type I γ chain replaces the deficient T cell receptor ζ chain in T cells of patients with systemic lupus erythematosus
19. Hyper-expression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production
20. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes
21. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus
22. Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases
23. Adenylyl cyclases and the interaction between calcium and cAMP signalling
24. 2+ release by cAMP-dependent protein kinase: A mechanism for agonist-specific calcium signaling?
25. CD3 stimulation causes phosphorylation of phospholipase C-gammal on serine and tyrosine residues in a human T-cell line
26. cAMP inhibits the OKT3-induced increase in cytoplasmic free calcium in the Jurkat T cell line: The degree of inhibition correlates inversely with the amount of CD3 binding ligand used
27. Inhibition of CD3-linked phospholipase C by phorbol ester and by cAMP is associated with decreased phosphotyrosine and increased phosphoserine contents of PLC-γ1
28. Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation: Association with protein kinase A-mediated phosphorylation of phospholipase C-γ1
29. 2+ release by cAMP-dependent protein kinase in a living cell
30. Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus
31. Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus
32. Impaired mobility of human T lymphocyte surface molecules during inactive systemic lupus erythematosus: Relationship to a defective cAMP pathway
33. Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus: Evidence for a disorder intrinsic to the T lymphocyte
34. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes
35. Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RIIβ-subunit in systemic lupus erythematosus T lymphocytes
36. High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus
37. Deficient type I protein kinase A activity in systemic lupus erythematosus T lymphocytes. II. Abnormal isozyme kinetics
38. Diminished levels of protein kinase A RIα and RIβ transcripts and proteins in systemic lupus erythematosus T lymphocytes
39. Protein kinase A RIβ-subunit deficiency in lupus T lymphocytes: Bypassing a block in RIβ translation reconstitutes protein kinase A activity and augments IL-2 production
40. mRNA mutations of the RIα-subunit of type I protein kinase A in T lymphocytes of subjects with systemic lupus erythematosus
41. Up-regulation of the transcript editing gene double-stranded RNA adenosine deaminase (ADAR) in SLE T lymphocytes
42. Identification of hot spots for transcript mutations in type I protein kinase A regulatory subunit alpha (PKA RIα) gene transcripts of SLE T lymphocytes
43. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus
44. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families
45. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome Iq in African-American pedigrees
46. Genome screening in human systemic lupus erythematosus: Results from a second Minnesota cohort and combined analyses of 187 sib-pair families
47. Mapping of the regulatory subunits RIβ and RIIβ of cAMP-dependent protein kinase genes on human chromosome 7
48. Apoptosis and programmed cell death in immunity
49. The Fas death factor
50. The apoptosis-1/Fas protein in human systemic lupus erythematosus
51. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: Role of decreased intracellular TNF-α
52. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
53. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling
54. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis
55. BAX-induced cell death may not require interleukin 1-converting enzyme-like proteases
56. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by bcl-2
57. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C
58. Antioxidant and redox regulation of gene transcription
59. Is NF-κB the sensor of oxidative stress?
60. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice
61. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses
62. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand
63. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: Correlation with disease activity
64. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression
65. BCL-2 family members and the mitochondria in apoptosis
66. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus
67. L prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis
68. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
69. Role of free radicals and catalytic metal ions in human disease: An overview
70. Mitochondrial physiology and pathology: Concepts of programmed death of organelles, cells, and organisms
71. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-l-one by nuclear size transformation
72. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens
73. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis
74. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis
75. Methylation-induced repression: Belts, braces and chromatin
76. + T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice
77. Mechanisms of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo
78. Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo
79. Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity
80. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupus-like disease in syngeneic mice
81. LFA-1 over-expression and T cell autoreactivity: Mechanisms
82. + T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: A model to explain spontaneous T cell activation in lupus
83. Decreased ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients
84. Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity
85. Regulation of the DNA methyltransferase by the Ras-AP-I signaling pathway
86. Role of the ras-MAPK, signaling pathway in the DNA methyltransferase response to DNA hypomethylation
87. Analysis of proteins that interact with the IL-2 regulatory region in patients with rheumatic diseases
88. The ras signal transduction pathway
89. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways resuits sults in differential modulation of cytokine production
90. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
91. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus
92. Defective production of interleukin I and interleukin 2 in patients with systemic lupus erythematosus (SLE)
93. T cell-antigen-presenting cell interactions in human systemic lupus erythematosus: Evidence for heterogeneous expressions of multiple defects
94. Abnormal NF-kB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression
95. Analysis of T cell function in autoimmune murine strains: Defects in production and responsiveness to interleukin 2
96. Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene
97. Coupling gene expression to cAMP signalling: Role of CREB and CREM
98. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy
99. Transcriptional regulation by cyclic AMP
100. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus
101. PKR: A sentinel kinase for cellular stress
102. PKR, apoptosis and cancer
103. Tight binding of the phosphorylated alpha subunit of initiation factor 2 (elF2α) to the regulatory subunits of guanine nucleotide exchange factor eIF2β is required for inhibition of translation initiation
104. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients
105. Impaired immunoregulation in systemic lupus erythematosus: Defective adenosine-induced suppressor T lymphocyte generation
106. Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells
107. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity
108. Serum IL-10 titers in SLE reflect disease activity
109. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus
110. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus
111. Inflammation in autoimmunity: Receptors for IgG revisited
112. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus
113. p561ck activity and expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus
114. Protein kinase CO: A new essential superstar on the T-cell stage
115. Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus
116. Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus
117. Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells
118. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression
119. Role of covalent modifications of histones in regulating gene expression
120. Histone acetylases and deacetylases in cell proliferation
121. Histone deacetylases: Silencers for hire
122. Trichostatin A reverses skewed expression of CD154, interleukin-10 and interferon-γ gene and protein expression in lupus T cells